Mirati Therapeutics, Inc.

MRTX · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$235,260$413,083$1,390,106$415,050
Short-Term Investments$848,577$1,078,257$0$0
Receivables$865$0$0$1,566
Inventory$3,020-$2,513-$2,304-$1,566
Other Curr. Assets$21,239$16,643$13,537$9,357
Total Curr. Assets$1,108,961$1,507,983$1,403,643$424,407
Property Plant & Equip (Net)$53,662$53,504$47,699$1,776
Goodwill$0$0$0$0
Intangibles$14,914$0$0$0
Long-Term Investments$3,465$8,218$15,629$0
Tax Assets$0$0$0$0
Other NC Assets$21,645$19,049$9,157$6,017
Total NC Assets$93,686$80,771$72,485$7,793
Other Assets$0$0$0$0
Total Assets$1,202,647$1,588,754$1,476,128$432,200
Liabilities
Payables$38,861$35,163$18,117$48,082
Short-Term Debt$7,844$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0-$1,341$0$824
Other Curr. Liab.$112,743$108,495$53,355$0
Total Curr. Liab.$159,448$143,658$71,472$48,906
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$999
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$46,683$48,058$43,867$0
Total NC Liab.$46,683$48,058$43,867$999
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$206,131$191,716$115,339$49,905
Equity
Pref Stock$0$0$0$0
Common Stock$58$55$50$40
Retained Earnings-$2,452,889-$1,712,022-$1,130,238-$772,301
AOCI-$3,719$9,068$9,759$9,889
Other Equity$3,453,066$3,099,937$2,481,218$1,144,667
Total Equity$996,516$1,397,038$1,360,789$382,295
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,202,647$1,588,754$1,476,128$432,200
Net Debt-$227,416-$413,083-$1,390,106-$415,050
Mirati Therapeutics, Inc. (MRTX) Financial Statements & Key Stats | AlphaPilot